Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Janux Therapeutics (JANX) Insider Trading & Ownership

$44.50
-0.93 (-2.05%)
(As of 10/1/2024 ET)

Janux Therapeutics (NASDAQ:JANX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
35.40%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$4.99 M
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$182.11 M

JANX Insider Buying and Selling by Quarter

Janux Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/30/2024Ventures Xi L.P. AvalonMajor ShareholderSell958$46.24$44,297.92  
9/27/2024Andrew Hollman MeyerInsiderSell50,000$45.96$2,298,000.00  
9/27/2024David Alan CampbellCEOSell25,000$46.31$1,157,750.00  
9/27/2024Ventures Xi L.P. AvalonMajor ShareholderSell49,231$46.45$2,286,779.95  
9/12/2024Ventures Xi L.P. AvalonMajor ShareholderSell158,031$47.00$7,427,457.00  
9/9/2024Ventures Xi L.P. AvalonMajor ShareholderSell2,182$42.33$92,364.06  
Get Ready for Next Week’s Elon Musk Shock (Ad)

I believe Elon Musk is about to shock the world again next week… When he’s set to unveil his new AI product. I’m hosting a special online strategy session to help you prepare on Monday at 10am ET.

Click here to see the details and save your seat.
9/6/2024Ventures Xi L.P. AvalonMajor ShareholderSell108,365$42.00$4,551,330.00  
6/3/2024Jay LichterDirectorSell1,500,000$54.75$82,125,000.00  
6/3/2024Tighe ReardonCFOSell822,721$54.75$45,043,974.75  
6/3/2024Ventures Xi L.P. AvalonMajor ShareholderSell677,279$54.75$37,081,025.25  
11/13/2023Ventures Xi L.P. AvalonMajor ShareholderBuy849,854$5.87$4,988,642.98  
(Data available from 1/1/2013 forward)

JANX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Janux Therapeutics includes Andrew Hollman Meyer, David Alan Campbell, Jay Lichter, Ra Capital Management, L.P., Tighe Reardon, and Ventures Xi L.P. Avalon. Learn more on insiders at JANX.

35.40% of Janux Therapeutics stock is owned by insiders. Learn more on JANX's insider holdings.

The following insiders have purchased JANX shares in the last 24 months: Ra Capital Management, L.P. ($6,167,799.68), and Ventures Xi L.P. Avalon ($4,988,642.98).

Insiders have purchased a total of 1,344,862 JANX shares in the last 24 months for a total of $11,156,442.66 bought.

The following insiders have sold JANX shares in the last 24 months: Andrew Hollman Meyer ($2,298,000.00), David Alan Campbell ($1,157,750.00), Jay Lichter ($82,125,000.00), Tighe Reardon ($45,043,974.75), and Ventures Xi L.P. Avalon ($51,483,254.18).

Insiders have sold a total of 3,393,767 Janux Therapeutics shares in the last 24 months for a total of $182,107,978.93 sold.



This page (NASDAQ:JANX) was last updated on 10/2/2024 by MarketBeat.com Staff
From Our Partners